FRED
$3.77
Fred's
($.19)
(4.80%)
Earnings Details
3rd Quarter October 2017
Wednesday, December 6, 2017 7:00:01 AM
Tweet Share Watch
Summary

Fred's (FRED) Recent Earnings

Fred's (FRED) reported a 3rd Quarter October 2017 loss of $0.42 per share on revenue of $493.6 million. The consensus estimate was a loss of $0.15 per share on revenue of $500.5 million. Revenue fell 4.5% compared to the same quarter a year ago.

Fred' Inc, and subsidiaries sells general merchandise through its retail discount stores and full service pharmacies.

Results
Reported Earnings
($0.42)
Earnings Whisper
-
Consensus Estimate
($0.15)
Reported Revenue
$493.6 Mil
Revenue Estimate
$500.5 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Fred’s Inc. Reports Third Quarter 2017 Results

Fred’s Inc. ("Fred’s" or "Company") (FRED) today reported financial results for the third quarter and nine months ended October 28, 2017.

For the third quarter ended October 28, 2017, Fred’s recorded a net loss of approximately $51.8 million or $1.38 per share, which included the following charges totaling $45.0 million, or $0.96 per share after tax:

$20.1 million or $0.53 per share for a valuation allowance against the Company’s deferred tax asset resulting from the pretax loss recorded during the third quarter;

$17.1 million or $0.30 per share after tax for a write down of unproductive inventory;

$5.2 million or $0.09 per share after tax for professional and legal advisory fees incurred in connection with the development and implementation of the Company’s turnaround strategy; and

$2.6 million or $0.04 per share after tax for asset impairment for the sale of corporate airplane.

Fred’s third quarter loss compares to a net loss of $38.4 million or $1.05 per share for the third quarter of 2016.

Commenting on today’s results, Michael K. Bloom, Chief Executive Officer, said, "We recognize that our EPS results are below expectations; however, the management team, working closely with the Board of Directors, is taking the actions necessary to ensure Fred’s achieves profitability and growth over the long-term. Our third quarter EPS and EBITDA, excluding non-operating charges, was negatively impacted by a more aggressive inventory reduction and timing of shipments for higher margin seasonal merchandise, which led to inventory levels nearly $50 million below the prior year, as well as investments in our overall pricing strategy to ensure we remain competitive in the market. While these initiatives impacted our gross margins, our cash flow plan remains on track as we streamline our business for the benefit of the Company’s long-term success."

Mr. Bloom continued, "In the third quarter, we furthered our efforts to turn around the Company, and we are encouraged by our positive front store comp sales in both October and November. We are focused on driving traffic, reducing SG&A, generating free cash flow and lowering our debt. We are aggressively executing our turnaround strategy to accomplish these goals, and we are seeing traction in both front store and pharmacy. We have witnessed a complete turnaround in our tobacco business, significantly enhanced cosmetics and successfully rolled out beer to approximately 150 stores and wine to approximately 50 stores. We have also kicked off a reduced price endcap test, which is showing promising results, and we intend to roll it out to all stores. We are not yet at the point of presenting positive quarterly comp sales and traffic improvement; however, we are improving month-by-month as our initiatives are yielding results. We recognize that there is more work to be done, but we are encouraged by the traction our initiatives are gaining and look forward to capitalizing on that momentum in the coming quarters."

Third Quarter 2017

Net sales for the third quarter were $493.6 million, down 4.5% from $516.6 million in the same period last year mainly driven by the closure or 39 underperforming stores earlier in 2017. Comparable store sales for the third quarter declined 0.8% versus a decrease of 3.8% in the third quarter last year. Comparable store sales in the third quarter of 2017 included a negative 36 BPS impact as a result of the sale of low productive discontinued inventory versus the third quarter of 2016.

Gross profit for the third quarter of 2017 decreased to $94.6 million from $111.2 million in the prior-year period, primarily explained by a decrease in sales resulting from the closure of 39 underperforming stores and an increase in the promotional activity to drive traffic and decrease inventory balances. Gross margin for the quarter decreased 230 basis points to 19.2% from 21.5% in the same quarter last year, reflecting the contribution of incremental sales of low margin specialty drugs and tobacco products, and a shift in timing of shipments to our stores of high margin seasonal items.

Fred’s recorded a LIFO reserve increase of $1.5 million in the third quarter of 2017 compared with an increase of $2.1 million in the same quarter last year.

Selling, general and administrative ("SG&A") expenses for the quarter, including depreciation and amortization, decreased to $144.4 million or 29.3% of sales from $155.3 million or 30.0% of sales in the prior-year quarter. The decrease in expenses was primarily driven by our increased focus on expense controls, the closure of 39 underperforming stores in early 2017, and the change in asset impairments recorded in the third quarter of 2017 versus the third quarter of 2016.

For the third quarter of 2017, operating loss, which is equivalent to earnings before interest and taxes, or EBIT, a non-GAAP financial measure, was a loss of $49.8 million compared with operating loss of $44.1 million in the same quarter last year.

In the third quarter of 2017, EBITDA, a non-GAAP financial measure that further excludes depreciation and amortization from EBIT, was a loss of $38.8 million. Third quarter EBITDA included charges totaling $24.9 million, including:

$17.1 million or $0.30 per share after tax for the write down of unproductive inventory;

$5.2 million or $0.09 per share after tax for professional and legal advisory fees incurred in connection with the development and implementation of the Company’s turnaround strategy; and

$2.6 million or $0.04 per share after tax for asset impairment for the sale of corporate airplane.

First Nine Months Ended October 28, 2017

For the first nine months ended October 28, 2017, Fred’s recorded a net loss of approximately $117.8 million or $3.14 per share, which included the following charges totaling $120.0 million, or $2.51 per share after tax:

$45.9 million or $1.23 per share after tax for a valuation allowance against the Company’s deferred tax asset resulting from the pretax loss created primarily by the following charges in the first nine months of 2017;

$37.3 million or $0.64 per share after tax for bank fees, financing termination fees, other professional and legal advisory fees incurred in connection with the proposed acquisition of Rite Aid stores and the development and implementation of the Company’s turnaround strategy;

$17.1 million or $0.30 per share after tax for a write down of unproductive inventory;

$16.3 million or $0.28 per share after tax for lease liability impairment, asset impairments and other expenses pertaining to the closure of 39 underperforming stores and the planned closure of 13 stores and certain pharmacy departments, as part of Fred’s ongoing asset management of its overall chain;

$2.6 million or $0.05 per share after tax for asset impairment for the sale of corporate airplane; and

$0.8 million or $0.01 per share after tax for other non-recurring charges.

Fred’s loss for the first nine months ended October 28, 2017 compares to a net loss of $44.1 million or $1.20 per share for the first nine months of 2016.

Net sales for the first nine months were $1.534 billion, down 3.9% from $1.596 billion in the same period last year mainly driven by the closure or 39 underperforming stores earlier in 2017. Comparable store sales for the first nine months declined 0.8% versus a decrease of 1.7% in the first nine months last year. Comparable store sales in the first nine months of 2017 included a negative 87 BPS impact as a result of the sale of low productive discontinued inventory versus the same period in 2016.

Gross profit for the first nine months decreased to $353.5 million from $380.7 million in the prior-year period, primarily explained by a decrease in sales resulting from the closure of 39 underperforming stores and an increase in promotional activity to drive traffic and decrease inventory balances. Gross margin for the first nine months decreased 80 basis points to 23.1% from 23.9% in the same period last year, reflecting the contribution of incremental sales of low margin specialty drugs and tobacco products, and a shift in timing of shipments to our stores of high margin seasonal items.

Fred’s recorded a LIFO reserve increase of $0.3 million in the first nine months of 2017 compared with an increase of $3.2 million in the same period last year.

SG&A expenses, including depreciation and amortization, increased to $465.6 million or 30.4% of sales from $433.2 million or 27.2% of sales in the prior-year period. The increase in expenses was primarily driven by professional, bank and legal advisory fees recorded in 2017 in connection with the proposed acquisition or Rite Aid stores and the development and implementation of the Company’s turnaround strategy; offset somewhat by our increased focus on expense controls and the closure of 39 underperforming stores in early 2017.

For the first nine months of 2017, operating loss, which is equivalent to earnings before interest and taxes, or EBIT, a non-GAAP financial measure, was a loss of $112.0 million compared with operating loss of $52.5 million in the same period last year.

In the first nine months of 2017, EBITDA, a non-GAAP financial measure that further excludes depreciation and amortization from EBIT, was a loss of $78.1 million. EBITDA included charges totaling $73.9 million, including:

$37.3 million or $0.64 per share after tax for bank fees, financing termination fees, prior period deferred expenses recognized in the current quarter for certain contract terminations and amendments, and other professional and legal advisory fees incurred in connection with the proposed acquisition of Rite Aid stores; the development and implementation of the Company’s turnaround strategy; and other professional and legal advisory fees;

$17.1 million or $0.30 per share after tax for the write down of unproductive inventory;

$16.1 million or $0.28 per share after tax for asset impairments and other expenses pertaining to the closure of 39 underperforming stores and the planned closure of 13 stores and certain pharmacy departments, as part of Fred’s ongoing asset management of its overall chain;

$2.6 million or $0.05 per share after tax for asset impairment for the sale of corporate airplane, and

$0.8 million or $0.01 per share after tax for other non-recurring charges.

In a separate press release issued today, the Company announced the cancelation of its dividend, an update to its share repurchase program and a review of alternatives for certain non-core assets. The Board of Directors determined to cancel the quarterly cash dividend in order to retain free cash flow for debt reduction, share repurchases and other general corporate purposes.

Webcast Information

A public, listen-only simulcast and replay of Fred’s third quarter 2017 conference call may be accessed at the Company’s web site. The simulcast will begin at 8:00 a.m. Eastern Time today; a replay of the call will be available beginning two hours after the conclusion of the live call and will remain available through January 4, 2018.

Non-GAAP Financial Measures

The Company’s management believes that the disclosure of operating income (EBIT) and EBITDA provides useful information to investors because the measures present an alternative and more relevant method for measuring the Company’s results of operations and financial condition, and, when viewed together with the Company’s GAAP results and the accompanying reconciliations, provides a more complete understanding of the factors and trends affecting the Company than the GAAP results alone. Additionally, EBITDA is a common alternative measure of financial performance used by investors, financial analysts, and rating agencies. These groups use EBITDA, along with other measures, to estimate the value of a company and to compare the operating performance of a company to others in its industry. A reconciliation of these non-GAAP financial measures to their most directly comparable GAAP measure appears in the financial tables attached to this news release.

About Fred’s Inc.

Tracing its history back to an original store in Coldwater, Mississippi, opened in 1947, today Fred’s, Inc. operates approximately 600 general merchandise and pharmacy stores, including 13 franchised locations, and three specialty pharmacy-only locations. With unique store formats and strategies that combine the best elements of a value-focused retailer with a healthcare-focused drug store, Fred’s stores offer frequently purchased items that address the everyday needs of its customers. This includes nationally recognized brands, proprietary Fred’s label products, and a full range of value-priced selections.

For more information about the Company, visit Fred’s website at www.fredsinc.com.

Forward Looking Statements

Comments in this news release that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. A reader can identify forward-looking statements because they are not limited to historical facts or they use such words as "outlook," "guidance," "may," "should," "could," "believe," "anticipate," "plan," "expect," "estimate," "forecast," "goal," "intend," "committed," "continue," or "will likely result" and similar expressions that concern the Company’s strategy, plans, intentions or beliefs about future occurrences or results. These risks and uncertainties include, but are not limited to (i) the competitive nature of the industries in which we operate; (ii) the implementation of our strategic plan, and its impact on our sales, costs and operations; (iii) utilizing our existing and new stores and increasing our pharmacy department presence in new and existing stores; (iv) our reliance on a single supplier of pharmaceutical products; (v) our pharmaceutical drug pricing; (vi) reimbursement rates and the terms of our agreements with pharmacy benefit management companies; (vii) our private brands; (viii) the seasonality of our business and the impact of adverse weather conditions; (ix) operational difficulties; (x) merchandise supply and pricing; (xi) consumer demand and product mix; (xii) delayed openings and operating new stores and distribution facilities; (xiii) our employees; (xiv) risks relating to payment processing; (xv) our computer system, and the processes supported by our information technology infrastructure; (xvi) our ability to protect the personal information of our customers and employees; (xvii) cyber-attacks; (xviii) changes in governmental regulations; (xix) the outcome of legal proceedings, including claims of product liability; (xx) insurance costs; (xxi) tax assessments and unclaimed property audits; (xxii) current economic conditions; (xxiii) changes in third-party reimbursements; (xxiv) the terms of our existing and future indebtedness; (xxv) our acquisitions and the ability to effectively integrate businesses that we acquire; (xxvi) our ability to pay dividends; and the factors listed under "Risk Factors" in the Company’s most recent Annual Report on Form 10-K and any subsequent quarterly filings on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made. The Company undertakes no obligation to release revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unforeseen events, except as required to be reported under the rules and regulations of the Securities and Exchange Commission.

FRED’S, INC.
Reconciliation of Unaudited Net Loss to EBITDA
A Non-GAAP Financial Measure
(In thousands)
13 Weeks Ended
13 Weeks Ended
39 Weeks Ended
39 Weeks Ended
October 28,
October 29,
October 28,
October 29, 2016
2017
2016
2017
Net loss
$ (51,815 )
$ (38,393 )
$ (117,793 )
$ (44,065 )
Interest expense
1,647
560
4,371
1,685
Income tax provision / (benefit)
415
(6,229 )
1,394
(10,162 )
Operating loss / EBIT
(49,753 )
(44,062 )
(112,028 )
(52,542 )
Depreciation and amortization
10,970
12,002
33,892
35,326
EBITDA
$ (38,783 )
$ (32,060 )
$
(78,136 )
$ (17,216 )
FRED’S, INC.
Unaudited Financial Highlights
(In thousands, except per share amounts)
13 Weeks Ended
13 Weeks Ended
October 28,
October 29,
2017
2016
Net sales
$
493,585
$
516,645
Operating loss
(49,753 )
(44,062 )
Net loss
(51,815 )
(38,393 )
Net loss per share, basic and diluted
$
(1.38 )
$
(1.05 )
Average shares outstanding:
Basic
37,626
36,810
Diluted
37,626
36,810
39 Weeks Ended
39 Weeks Ended
October 28,
October 29,
2017
2016
Net sales
$ 1,533,742
$ 1,595,696
Operating loss
(112,028 )
(52,542 )
Net loss
(117,793 )
(44,065 )
Net loss per share, basic and diluted
$
(3.14 )
$
(1.20 )
Average shares outstanding:
Basic
37,481
36,768
Diluted
37,481
36,768
FRED’S, INC.
Unaudited Fiscal 2017 Third Quarter Results
(In thousands, except per share amounts)
13 Weeks Ended
% of
13 Weeks Ended
% of
October 28,
Total
October 29,
Total
2017
2016
Net sales
$
493,585
100.0 %
$
516,645
100.0 %
Cost of goods sold
398,967
80.8 %
405,439
78.5 %
Gross profit
94,618
19.2 %
111,206
21.5 %
Depreciation & amortization
10,970
2.2 %
12,002
2.3 %
Selling, general and administrative expenses
133,401
27.1 %
143,266
27.7 %
Operating loss
(49,753 )
(10.1 )%
(44,062 )
(8.5 )%
Interest expense, net
1,647
0.3 %
560
0.1 %
Loss before income taxes
(51,400 )
(10.4 )%
(44,622 )
(8.6 )%
Income tax provision (benefit)
415
0.1 %
(6,229 )
(1.2 )%
Net loss
$
(51,815 )
(10.5 )%
$
(38,393 )
(7.4 )%
Net loss per share,
$
(1.38 )
$
(1.05 )
basic and diluted
Weighted average shares outstanding:
Basic
37,626
36,810
37,626
36,810
Diluted
39 Weeks Ended
% of
39 Weeks Ended
% of
October 28,
Total
October 29,
Total
2017
2016
Net sales
$ 1,533,742
100.0 %
$ 1,595,696
100.0 %
Cost of goods sold
1,180,213
76.9 %
1,215,030
76.1 %
Gross profit
353,529
23.1 %
380,666
23.9 %
Depreciation & amortization
33,892
2.2 %
35,326
2.2 %
Selling, general and administrative expenses
431,665
28.2 %
397,882
25.0 %
Operating loss
(112,028 )
(7.3 )%
(52,542 )
(3.3 )%
Interest expense, net
4,371
0.3 %
1,685
0.1 %
Loss before income taxes
(116,399 )
(7.6 )%
(54,227 )
(3.4 )%
Income tax provision (benefit)
1,394
0.1 %
(10,162 )
(0.6 )%
Net loss
$
(117,793 )
(7.7 )%
$
(44,065 )
(2.8 )%
Net loss per share,
$
(3.14 )
$
(1.20 )
basic and diluted
Weighted average shares outstanding:
Basic
37,481
36,768
Diluted
37,481
36,768
FRED’S, INC.
Unaudited Balance Sheet
(In thousands)
October 28, 2017
October 29, 2016
ASSETS:
Cash and cash equivalents
$
5,113
$
5,692
Inventories
317,220
366,575
Receivables
56,922
52,740
Other non-trade receivables
30,597
36,959
Prepaid expenses and other current assets
10,898
12,634
Total current assets
420,750
474,600
Property and equipment, net
121,324
133,360
Goodwill
41,490
41,490
Other intangible assets, net
69,972
90,377
Other non-current assets
999
1,050
Total assets
$
654,535
$
740,877
LIABILITIES AND SHAREHOLDERS’ EQUITY:
Accounts payable
$
152,943
$
214,818
Current portion of indebtedness
63
59
Accrued expenses and other
83,897
71,071
Total current liabilities
236,903
285,948
Long-term portion of indebtedness
168,196
77,234
Deferred income taxes
3,261
-
Other non-current liabilities
27,873
21,797
Total liabilities
436,233
384,979
Shareholders’ equity
218,302
355,898
Total liabilities and shareholders’ equity
$
654,535
$
740,877

http://cts.businesswire.com/ct/CT?id=bwnews&sty=20171206005320r1&sid=cmtx6&distro=nx&lang=en

View source version on businesswire.com: http://www.businesswire.com/news/home/20171206005320/en/

SOURCE: Fred’s Inc.

Fred’s Inc.
Jason Jenne, 901-238-2787
Executive Vice President, Chief Financial Officer and Secretary
or
Joele Frank, Wilkinson Brimmer Katcher
Ed Trissel / Dan Moore, 212-355-4449